Why Choose Semaglutide
Jan 12, 2026 | 3:12 PM Microdosing GLP-1 Medications: Why a Slower Approach Can Lead to Better Results For many people considering GLP-1 medications like semaglutide, the promise of weight loss or metabolic improvement is paired with concern
Key pathophysiologic mechanisms include: Mucosal barrier dysfunction: Impaired epithelial tight junctions allow bacterial translocation, triggering innate immune activation T-helper cell dysregulation: Predominantly Th1 and Th17 pathways drive chronic inflammation via TNF-, IL-12, IL-23 the basis for biologic therapy targets Transmural inflammation: Unlike UC (mucosal only), CD involves all layers: mucosa submucosa muscularis propria serosa Granuloma formation: Non-caseating granulomas are pathognomonic but present in only ~3050% of biopsies Fibrosis and stricture: Chronic inflammation activates myofibroblasts collagen deposition luminal narrowing obstructive symptoms Fistula formation: Transmural ulcers penetrate serosa form sinus tracts connect to adjacent bowel, bladder, vagina, or skin 7
If youre struggling to lose those stubborn extra pounds in the Garden City region, GLP-1 Agonist could be the solution youve been searching for
Functions of the peroxisome proliferator-activated receptor (PPAR) alpha and beta in skin homeostasis, epithelial repair, and morphogenesis
&srotate=0)
